H
%Start Study: How Statins Slow Growth of Prostate Cancer Cedars-Sinai Skip to content Close
Select your preferred language English عربى 简体中文 繁體中文 فارسي עִברִית 日本語 한국어 Русский Español Tagalog English English عربى 简体中文 繁體中文 فارسي עִברִית 日本語 한국어 Русский Español Tagalog Translation is unavailable for Internet Explorer Cedars-Sinai Home 1-800-CEDARS-1 1-800-CEDARS-1 Close Find a Doctor Locations Programs & Services Health Library Patient & Visitors Community My CS-Link RESEARCH clear Go Close Navigation Links Academics Faculty Development Community Engagement Calendar Research Research Areas Research Labs Departments & Institutes Find Clinical Trials Research Cores Research Administration Basic Science Research Clinical & Translational Research Center (CTRC) Technology & Innovations News & Breakthroughs Education Graduate Medical Education Continuing Medical Education Graduate School of Biomedical Sciences Professional Training Programs Medical Students Campus Life Office of the Dean Simulation Center Medical Library Program in the History of Medicine About Us All Education Programs Departments & Institutes Faculty Directory 2022 Research News Back to 2022 Research News
Study How Statins Slow Growth of Prostate Cancer Cedars-Sinai Cancer investigators have found that lowering blood cholesterol enhances the action of immune cells, thus slowing the growth of prostate cancer. Their research, conducted in humans and mice, was published in the peer-reviewed journal Clinical Cancer Research and provides a rationale for large-scale clinical testing of using cholesterol-lowering therapy to prevent prostate cancer progression.
visibility
320 views
thumb_up
23 likes
S
There is currently no widely accepted medication that prevents the formation or progression of prostate cancer, the most commonly diagnosed cancer and second-leading cause of cancer death among men in North America. Previous research has shown that men who take cholesterol-lowering drugs called statins, which are widely prescribed for heart health, also seem to have a lower risk of dying from prostate cancer.
thumb_up
47 likes
C
Studies have also shown that lowering cholesterol decreases the growth of prostate tumors in mice. "Our studies add to this by establishing cause and effect," said Hyung Kim, MD, associate director of Surgical Research at Cedars-Sinai Cancer and senior author of the studies.
thumb_up
49 likes
S
"They also establish that lowering cholesterol acts through the immune system and not just directly on cancer cells." Investigators placed 27 prostate cancer patients on two to six weeks of cholesterol-lowering therapy while the patients awaited prostate cancer surgery. The patients received simvastatin, a statin that slows the production of cholesterol in the liver.
thumb_up
24 likes
A
They also received ezetimibe, a drug that prevents cholesterol from being absorbed in the gut. The combination of the two drugs lowers cholesterol more efficiently than would be possible with a statin alone.
thumb_up
2 likes
E
Hyung L. Kim, MD The investigators compared samples of the patients' tumors and blood from before and after the cholesterol-lowering intervention. They found that the intervention limited the signaling of the mTOR complex 2 (mTORC2) protein in CD8+ lymphocytes, which are immune cells that Kim called "the primary workhorse" of the adaptive immune system.
thumb_up
43 likes
S
The mTORC2 protein is important to cell growth, but the connection between mTORC2 and cholesterol hadn't been established until this study, Kim said. With the patients' cholesterol lowered and mTORC2 signaling reduced, their CD8+ cells—which have memory that allows them to recognize invading pathogens and cancers—were able to invade their prostate cancer tumors and reduce the tumors' growth. The researchers traced this cause-and-effect relationship in greater detail through experiments in laboratory mice with prostate tumors.
thumb_up
24 likes
E
Investigators knocked out mTORC2 signaling in the immune cells of mice that did not receive cholesterol-lowering therapy, and they found that these mice saw the same tumor-inhibiting benefits as mice that had received cholesterol-lowering therapy. This established that the cholesterol-lowering therapy works through this pathway. To confirm that it was the CD8+ immune cells attacking the tumors, investigators transferred these cells from mice that had received cholesterol-lowering therapy into mice that had not.
thumb_up
6 likes
W
The cells acted against the tumors, slowing their growth. And when investigators depleted CD8+ immune cells in mice that had received cholesterol-lowering therapy, their tumors grew as if they had received no treatment. "We showed in these animal models that lowering cholesterol decreases tumor growth through the immune system, which is a new observation," said Kim, who is also a professor of Surgery, the director of the Academic Urology Program, and the Homer and Gloria Harvey Family Chair in Urologic Oncology in honor of Stuart Friedman, MD, at Cedars-Sinai.
thumb_up
44 likes
D
"We have parallel studies in humans and mice and have been able to identify a fairly detailed mechanism by which this happens: Serum cholesterol goes down, mTORC2 signaling goes down, immune cells move into the tumor and tumor growth then goes down." Developing and testing a new drug to reduce mTORC2 signaling directly could take 10 years or more, but cholesterol-lowering medications are widely available and have been approved by the Food and Drug Administration for heart health, Kim said. "So you have a safe, widely available intervention that has cardiovascular benefits and could be tested in a large-scale clinical trial to see if it has a beneficial effect on prostate cancer," Kim said. "Our clinical observations in humans and the mechanism of action we identified in animal models make a strong case that this larger clinical trial ought to go forward." The study was funded by grants from the Samuel Oschin Comprehensive Cancer Institute, Winnick Family Foundation, Homer and Gloria Harvey Family Endowed Chair, the National Institutes of Health under award number R01CA182438, and the National Cancer Institute under award number UG1CA189823 to the Alliance for Clinical Trials in Oncology NCORP Research Base.
thumb_up
1 likes
M
Please ensure Javascript is enabled for purposes of website accessibility
thumb_up
3 likes
Similar Discussions
-
There were contacts in which I kept my position clear 28 year old winger reveals he rejected chance to join Jurgen Klopp s Liverpool
-
Barcelona star injured 20 seconds into international friendly reports
-
This guy is average My grandma would do better Barcelona fans blast horrendous display from player labelled fraud after goalless first half against Cadiz
-
Pokémon GO September 2022 All Field Research tasks and rewards including Medicham Encounter
-
My Colisée APK Download for Android APKfun com
-
แต่งรูปวันลอยกระทง APK Download for Android
-
St Mark s Orthodox Church APK Download for Android
-
Fishing River monsters APK Download for Android
-
Reste concentr Karim Benzema r pond J r me Rothen et lui envoie un norme tacle
-
China to ease share financing rules for property related firms but outlook bleak Bact Cdm
-
Emotiva despedida a Spiriman en Granada una multitudinaria concentraci n da su ltimo adi s al m dico Esther L pez
-
How Tumultuous Forces of Brexit Divided U K s Conservative Party Brexit Politics
-
Paintings That Look Like Photographs 45 Portraits By A Brazilian Artist
-
The Hurricane Ian Street Shark Is Real
-
Showstoppers Six music gigs that didn t end as they were supposed to
-
Reason number 758 we re glad Mike Huckabee isn t president
-
Is Dropshipping the Best First Business for Creatives?
-
Likes Don t Have to Ruin Social Networks If You Do Them Right
-
How to Hide Self View on Zoom
-
Converting an Excel Spreadsheet to Access 2013 Database
-
Say Hello To The New Lamborghini Huracan Evo CarBuzz
-
Winddruck in Silos und Schachtöfen Berechnung gewölbter Platten SpringerLink
-
Angewandte Statistik SpringerLink
-
What Is Right to Repair? iFixit News
-
Terapia de medicina nuclear Información sobre el tratamiento con medicina nuclear Mayo Clinic
-
8 benefits of cycling for women Blog Decathlon
-
Junior Clothes For Sale
-
The Fresh Beat Band Season 3 Dvd
-
How To Recognize And Reduce Water Retention Edema Everyday Health
-
Colostomy Johns Hopkins Medicine